Impact of our research

Research impact

World-leading research in the Department has a profound impact on advancing healthcare, society and the economy. We work closely alongside the Imperial College Healthcare NHS Trust (ICHNT) and healthcare delivery partners to transform our pioneering research into medical advances, new therapies and to inform healthcare policy and guidelines.

Facilitated by the National Institute for Health Research (NIHR) Imperial Biomedical Research Centre (BRC), research is rapidly transformed to improve healthcare outcomes.

Follow the links below for a selection of fascinating case studies with far-reaching impact from the Department of Medicine. This selection will be updated regularly with further successful research endeavours.

New hope for the treatment of Multiple Myeloma

Professor Guido Franzoso and his colleagues at Imperial College London have discovered a new way of tackling multiple myeloma, an incurable cancer of the white blood cells.

Advances in healthcare for newborns

Professor Neena Modi and her team at Imperial College have used a novel and innovative approach to address the lack of high quality data to advance healthcare for sick newborn babies.

Overcoming ovarian hyperstimulation syndrome via kisspeptin

Imperial College researchers are pioneering a safer way of preparing eggs for use in IVF by using the naturally occurring hormone kisspeptin to gently stimulate women's ovaries to produce eggs.

Treating inflammatory conditions with Remicade®

Research at Imperial College identified tumour necrosis factor as a key therapeutic target in the abnormal joint lining in rheumatoid arthritis.

Imperial spinout Thiakis develops a novel weight loss treatment

Novel weight loss treatment sold by Imperial for $30 million

Professor Steve Bloom’s group at Imperial College has pioneered the use of the gut hormone oxyntomodulin as natural appetite regulators.

Increasing the survival rate of oxygen-starved babies

Imperial College researchers have pioneered the implementation of therapeutic hypothermia to improve survival of babies following reduced oxygen at birth.